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Abstract
Outsourcing has shown itself worldwide to be a useful tool for improving partnership between private and public companies.
The budgetary constraints imposed by the Italian government on health industry are enhancing the urgency to outsource to face
costs. Our study deals with the relationship between ASLs (Aziende Sanitarie Locali, the Italian local health authority) and private
operators outsourcing in Italy.
We studied 44 pharmaceutical companies (with a yearly turnover of about e6 billion) and 34 ASLs (with about 12 million users)
to ﬁnd out the areas in which they used outsourcing, the amount and the frequency of such investment, their satisfaction and,
therefore, their future intentions. We analysed the answers in search for possible relationships between size, frequency of use and
other features to uncover a possible convergence between public and private interest in outsourcing.
To better evaluate the convergence we analyse and compare satisfaction of both the operators involved in outsourcing (ASL
and private operators). We aim to oﬀer a representation of the current state of outsourcing in the Italian Healthcare System and
a ﬁrst indication of possible contrasts in the relationship between public and private partners. The results suggest that public and
private operator have a diﬀerent satisfaction level and in particular their expectations are in contrast whit their satisfaction: ASLs
are generally more satisﬁed than pharmaceutical companies, but expect a considerable reduction of outsourced activities; private
companies are less satisﬁed and provide an increase in these activities.
c© 2014 The Authors. Published by Elsevier B.V.
Selection and peer-review under responsibility of the Organizing Committee of IES 2013.
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1. Introduction
Companies are forced to limit the economic exposure and to defend their market shares because of the recent
economic crises. To face this problem, they developed a wide range of business management tools and, nowadays,
even public companies are starting to apply them. In this study we focused our attention on outsourcing, a way to
increase ﬂexibility in Public Healthcare services, and in particular on its development in Italian Public Healthcare
companies. According to Fattore (2012), the Italian Public Health sector, although not subject to the competitive
market rules, is facing severe budget restrictions, depending on the Central Government need of spending reduction.
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Italian policy makers need to limit national debt and preserve high quality standards in the crucial area of Pub-
lic Healthcare intervention. National policy makers aim at increasing ﬂexibility and eﬃciency in public healthcare
services and making local governments more responsible about their healthcare spending.
These new operational conditions allow the Public Healthcare sector to outsource more extensively. Outsourcing
is a business tool largely employed in the private sector in order to increase ﬂexibility and to contain costs. Its use in
the public sector is increasing and various studies analysed its development (Macinati (2006), Mariani et al. (2011)).
We hypothesized that the level of satisfaction of public and private operators for the outsourced activities can aﬀect
the outsourcing development in Italian National Health Service. Under this hypothesis, we presented an overview of
outsourced activities with regard to speciﬁc areas of National Health Service (NHS) and we aimed at identifying the
current state and future prospects of partnership between public and private operators analysing the satisfaction of both
the operators and their expectation on the future investments on the activities, to assess the degree of correspondence
between the services oﬀered by pharmaceutical companies and those required by the ASLs.
For these purposes, we used the results of a survey carried out in Italy on the activities outsourced by territorial
health agencies: the ASLs (Aziende Sanitarie Locali, the Italian local health authority). We analysed speciﬁc out-
sourced healthcare services, not related to ASLs core activities (services of medical care and diagnosis). Ancillary
services, such as catering, cleaning etc., were excluded. The complementary services analysed in this paper are:
clinical trials, epidemiological / observational studies, patient focused projects, management training, data release/ ad
hoc research, patient monitoring, social marketing, CME (Continuing Medical Education). These services are taken
in charge by pharmaceutical companies, qualiﬁed interlocutors having the appropriate level of expertise to carry out
such activities. Therefore, we interviewed outsourcing policy makers, within the ASLs, and managers handling the
relations with the Public Healthcare within the pharmaceutical companies.
This study is structured as follows. Section 2 shows the framework in Italian Healthcare Public sector, Section 3
describes the research strategy and the data collection. In section 4, we present the empirical analysis and the results.
Section 5 concludes.
2. Theoretical framework
Italy, because of its high public debt, is one of the countries hit the hardest by the ﬁnancial crisis of recent years, and
Public Healthcare is a sector more exposed to organizational restructuring. The Italian National Health Service (NHS),
in addition to the problems of an aging population and an increasing migration, also faces the recent deterioration of
the economic condition of the country (Fattore (2012)).
In the three decades of its short existence, the eﬀort to maintain a high level of service quality required to Italian
National Health Service a massive outﬂow of resources. That mainly weighed in on the national budget, principally
because the policies adopted have not always been driven by economic logic. The result was a state of a long term
macroeconomic not sustainably situation, that today is no longer acceptable, given the severe economic crisis aﬀecting
Italy and decisive measures are required.
In recent years, the political debate on the reorganization and rationalization of public spending in healthcare has
been very intense. In the ﬁeld of healthcare budgets management, literature and policy makers followed two main
themes (Macinati (2008a)): 1) Devolution (the transfer or delegation of power to a lower level, especially by Central
Government to local or regional administration) and 2) Improvement of public services management eﬃciency. The
demand for greater eﬃciency in the delivery of public services is a result of heavy public debt crisis of 2011, when the
Italian government needed to restructure the whole sector of Public Spending, including the predominant component
of health care area. At ﬁrst, the response of the central government was dictated by the urgency and the gravity of the
situation. The measures taken, resulted mostly in “linear cuts” in Public Spending and health spending in particular.
Leaving aside considerations about the eﬀectiveness of such policies, some authors highlighted the potential increase
in inequality in access to health care and an ampliﬁed gap between the Italian regions due to the drastic and sudden
reduction in public health expenditure (Cappellaro et al. (2009)).
As an alternative to indiscriminate cuts in public spending, literature long proposed several business instruments to
enhance ﬂexibility and eﬃciency. In particular, regarding the best use of available public administration resources, it
is possible to refer to a train of thought that has been developed in literature for several years: managerialism (Fattore
(1999)). In the context of a wider decision-making autonomy of public providers, managerialism aims at identifying
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the incentives for adoption of innovative and ﬂexible business tools, so far neglected by policy makers. The indication
of managerialism had not immediately been transposed into Italian law, but for several years they remained at the
level of orientation.
Nowadays, ﬁnally, the local decision makers are giving a more managerial orientation to their policies, aware of
the evident beneﬁts it brings in terms of increasing eﬃciency in public activity (Macinati (2008b)). Outsourcing is
one of the tools that best ﬁt these needs.
Outsourcing consists in transferring services or operating functions, traditionally performed internally, to a third
party service provider and controlling the sourcing through contract and partnership management (Roberts (2001)).
Literature provides an extensive repertoire of outsourcing beneﬁts. In particular, there is a narrower subset of re-
searches focused on outsourcing in the healthcare sector. Macinati, in her literature review, (Macinati (2008a)) sum-
marize the main reasons for outsourcing in the public health care in:
• cost reductions and eﬃciency improvements;
• strategic considerations;
• acquisition of specialized technical skills concentrating resources on the development of internal strategic skills.
Even though outsourcing may have many potential beneﬁts, there are also several disadvantages that the previously
mentioned author (Macinati (2008a)) summarizes in:
• cost savings lower than expected and not available over the long term;
• Public Healthcare providers over-dependent on the vendor or liable for the vendor’s actions;
• Public Healthcare losing control over the standard of service delivering.
A further problem concerns the collaboration between demand and supply of outsourcing. In our work we intend
to provide an overview of the Italian situation in relation to this problem.
The actors involved in outsourcing partnerships, on the Public Healthcare side, primarily are the great Italian health
companies, such as Hospitals and ASLs . In this work we have chosen to consider only this latter and, in eﬀect, ASLs
diﬀer from hospitals because they both deliver care, but ASLs also deliver services, which are the object of our study.
In the public sector, speciﬁcally in the healthcare area, outsourcing consists overall in contracting-out: the public
decision maker commits the services production/supply to private external companies. The range of services that
NHS and in particular ASLs already contract-out is very wide, but the outsourced activities may be included in 4 main
categories (Macinati (2008a)):
• Ancillary Services
• Diagnostic Services
• Essential Services
• Community Services
Actually, the major advantages of outsourcing are that ASLs can concentrate economic resources and know-how
on core business activities (in the case of Public Healthcare, they primarily consist of medical and diagnostic services),
so they can commit to specialized external the complementary activities (ancillary clinical activities and community
services). For this reason the services analysed are fully included in the deﬁnition of complementary activities (clinical
trials, patient focused project, social marketing, CME etc.).
Given the speciﬁc technical skills required for the provision of such activities, the key partners for collaboration
are pharmaceutical companies operating in Italy.
We have now deﬁned the main subjects of this research, in the following section we present the methodology used
in the analysis.
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3. Methods and Data collection
In this research, we aimed at obtaining evaluation of both the partners (ASLs and pharmaceutical companies)
involved in outsourcing and the expected investments in these activities to evaluate its current in the Italian Healthcare
System and the future development. The research hypothesis was set up using a ﬁve-point Likert-type scale (from
“very dissatisﬁed” to “very satisﬁed”). A descriptive analysis was performed, and the association between satisfaction
and the remaining variables was measured for the two groups. The amount of data available was not large enough and
we could not apply the most advanced satisfaction analysis tools (Parasuraman et al. (1994), Fornell et al. (2005)).
On the other hand, we could use the Student’s t-test for two independent samples to compare the ASLs’ and Pharma’s
satisfaction (Kumar et al. (2013)). This test is robust enough for the sizes of our samples (Lehmann and Romano
(2006)) and we could test the diﬀerence between the means of ASLs’ and Pharma’s satisfaction.
3.1. The questionnaire
A survey was carried out to collect data on activities outsourced by ASLs and supplied by pharmaceutical compa-
nies. The questions aﬀected the current state of outsourcing and the future prospects. The data was collected in 2010.
The questionnaire, customized on ASLs and pharmaceutical companies, was structured with closed-ended question,
with single and multiple responses. The CATI method was used.
The common questions interested:
• the frequency of collaboration between ASLs and pharmaceutical companies;
• the mean value, in euro, of each collaboration (both present and future);
• an evaluation of these collaborations.
The ASLs were asked to indicate the person in charge of the decisions regarding outsourcing. Pharmaceutical
companies were asked to indicate the subject, within the company, in charge of the relations with the ASLs regarding
outsourcing, and to identify the position of the subject directly contacted within the ASLs.
Lastly, complementary services mentioned in section 2 were recorded. In the questionnaire the following 8 types
of relevant activities were identiﬁed:
1. Clinical trials;
2. Epidemiological/observational studies, aiming to gain knowledge on incidence, aetiology, diagnosis and treat-
ment of diseases or on their opposite, i.e., the state of health.
3. Patient focused projects.
4. Managerial training.
5. Data release/ ad hoc research.
6. Patient Monitoring (compliance to treatment).
7. Social marketing.
8. CME (Continual Medical Education).
We chose these activities because ASLs have the responsibility to provide them, but they do not represent a core
business service for Public Healthcare: this is a classic example of services economically convenient to outsource.
The issues regarding outsourcing activities, already in place and future, have been presented diﬀerently to respon-
dents.
ASLs were asked what activities they have and have intention to outsource. Pharmaceutical companies were asked
to indicate what might be, for the Public Healthcare policy maker, the most interesting activities to be placed in
outsourcing (among those already in place and among those which have yet to be put in place). In fact, we assumed
that the answers to this question are inﬂuenced by the relationships between respondents and Public Healthcare.
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3.2. Respondents
On the demand side, all 146 ASLs operating in Italy in 2010 were contacted (source: Ministry of Health 1.) 34
ASLs responded to survey, covering about 12 million of users (nearly one-ﬁfth of the Italian population).
On the supply side, 44 pharmaceutical companies participated in the survey. They summarized approximately e6
billion annual turnover in Italy and cover about 30% of the pharmaceutical product sales, slightly less than e20 billion
(source IMS Health 2010).
As the data obtained included a self-selected subset of the population, it was not possible to draw inferential
conclusions from the analysis. On the other hand, the survey enabled to outline an overview of the state of outsourcing
in the Italian Public Healthcare System.
4. Results
4.1. Structural data
Respondents were characterized with respect to their size. We grouped the ASLs into three categories (small,
medium, large) according to the number of residents: 61.8% of the ASLs were small sized, 23.5% were medium
sized, 14.7% were large sized.
The 44 private companies were classiﬁed by the turnover produced in Italy in three classes. The groups were
deﬁned as follows:
Less than e10 million of turnover: Small Company
Between e10 and 100 million of turnover: Medium Company
More than e100 million of turnover: Large Company.
Small companies represented 43.2% of respondents. 31.8% of companies were medium and 25.0% were large.
4.2. Descriptive analysis
From the analysis of annual frequency and average ﬁnancial value of collaboration, we could draw a ﬁrst indication
of the state of the partnership between ASLs and pharmaceutical companies.
55.6% of respondent ASLs outsourced up to a maximum of 5 activities per year. Respondents indicating an average
value for activities (outsourced on the whole Italian pharmaceutical market) exceeding e900,000 were 14.3%. 28.4%
of ASLs declared an average value between e300,000and 900.000; the remaining 57.1% declared a value under
e300,000.
Nearly one third of the pharmaceutical companies undertook collaborations with almost one of the 146 Italian
ASLs less than 6 times per year, while the remaining 65.9% had 6 or more opportunities for collaboration.
70% of respondents claimed to have outsourced business for an average value of less than e300,000. 10% of them
indicated a value between e300,000 and 900,000and the remaining 20% indicated a value greater than e900,000.
In order to expand the analysis, the average value of the outsourced activities was related to the remaining variables
(Table 1).
With regard to the size, only small ASLs outsourced activities for a high average value (25%). A quarter of small
ASLs and the totality of the big ones collaborated only for a medium value (between e300,000 and 900,000); half of
the small ASLs and the totality of the medium ones outsourced services for an average value of less than e300,000.
ASLs outsourcing with low frequency (less than 6 times a year) also had a low level of investment in outsourcing
(never more than e300,000). ASLs carrying out 6 or more collaborations were distributed on all classes of expendi-
ture, exceeding e900,000 in 20% of cases.
These results suggest that ASLs still tend to not invest large sums of money in outsourcing. Only one out of seven
respondent ASLs exceed e900,000 average expenditure, and in all cases they are small ASLs, having activated many
collaborations during the year (Table 1).
1 Ministry of Health, http://www.salute.gov.it/ (Retrieved: 16/12/2013)
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Table 1. Distribution of the variable “Value of the activities outsourced by the ASLs” in relation to the variables “Size” and “Frequency of use of
outsourcing”.
Value of the activities outsourced by ASLs
Up to e300,000 Between e300,000 More than e900,000
and e900,000
Small 50.0% 25.0% 25.0%
Size Medium 100.0% 0.0% 0.0%
Large 0.0% 100.0% 0.0%
Frequency of use of outsourcing Up to 5 times a year 100.0% 0.0% 0.0%
6 or more times a year 40.0% 40.0% 20.0%
Total* 57.1% 28.6% 14.3%
*(34 respondent ASL collaborating
with the whole pharmaceutical market)
Source: B-asc Research Centre. Based on research data.
Considering the distribution of private sector companies (Table 2), for pharmaceutical companies we have not
found a particular diﬀerentiation in investments: most of the respondents collaborated with the public sector for a
value not exceeding e300,000.
Table 2. Distribution of the variable “Value of the activities outsourced from the pharmaceutical companies” to ASL in relation to the variables
“Size” and “Frequency of use of outsourcing”.
Value of activities outsourced by pharmaceutical companies
Up to e300,000 Between e300,000 More than e900,000
and e900,000
Small 66.7% 11.1% 22.2%
Size Medium 66.7% 16.7% 16.7%
Large 80.0% 0.0% 20.0%
Frequency of use of outsourcing Up to 5 times a year 72.7% 9.1% 18.2%
6 or more times a year 66.7% 11.1% 22.2%
Total* 70.0% 10.0% 20.0%
*(44 respondent pharmaceutical companies
collaborating with the Local Health Care
organizations)
Source: B-asc Research Centre. Based on research data.
The distribution does not change considerably if we take into account the size of the companies and the outsourcing
frequency. More than two-thirds of private respondents collaborated for minor activities (not exceeding e300,000),
independently of size and outsourcing frequency. We could relive that the percentage of large companies outsourcing
for less than e300,000 is 80.0%, and none of them collaborated for a medium value.
For private operators, a substantial relationship between the value of activities carried out and the variables taken
into account was not detected. Size is the only variable which shows some relation. It should be noted, in fact, that the
distribution of the outsourcing value indicated by pharmaceutical companies is much more concentrated than ASLs
on minor activities (up to e300,000).
Our research interests required, in addition to the survey on the average extent of investment outsourced in the past,
an investigation into the future prospects. The levels of foreseen investment vary in opposite directions. Pharmaceuti-
cal companies predicted an increase in investment in outsourcing: the share of big investments (larger than e900,000)
goes from 20.0 to 22.2% of the respondents, as well as investments in the middle class (from e300,000 and 900,000)
vary from 10.0 to 16.7%.
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With regard to the ASL instead, the forecasts of the respondents indicated a drastic resizing. One out of ten
respondent ASLs planned to invest more than e900,000 (whilst 14.3% of them claim to have invested the same
amount in the past). The percentage of middle investments (between e300,000 and 900,000) decreases from 28.6%
to 10.0%, regarding the respondents forecasts. Less than e300,000 investments were carried out by less than 60% of
respondents but are expected from 80.0% of them. In the following paragraphs we use the analysis of satisfaction to
propose an explanation for this result.
4.3. Outsourcing operators evaluation
The research ﬁndings pointed out the diﬀerences between the satisfaction level of public and private operators.
They are in contradiction with the results of the analysis on prospected investments.
The mean satisfaction for public companies, on a ﬁve-point Likert-type scale, was equal to 3.8 but for private
companies was equal to 3.4. In fact, most of the Pharmaceutical companies were moderately satisﬁed (52.4%),
slightly more than 40% of the respondents were “satisﬁed” or “very satisﬁed”. About 7% of respondents said they
were “very dissatisﬁed”. On the contrary, no ASL respondent is dissatisﬁed. More than half of the public operators
were satisﬁed, and 12.9% of respondents said they were very satisﬁed. About a third of public companies said they
were slightly satisﬁed for outsourcing.
Table 3. Independent Samples Student’s T-Test for equality of means of “Satisfaction” variable.
Levene’s Test for Equality of T-test for Equality of Means
Variances
95%
Conﬁdence Interval
F Sig. t df Sig. Mean Std. Error of the Diﬀerence
(2-tailed) Diﬀerence Diﬀerence Lower Upper
Equal variances
assumed 1.640 0.204 2.870 73 0.005 0.475 0.166 0.145 0.805
Equal variances
not assumed 2.952 70.354 0.004 0.475 0.161 0.154 0.796
Source: B-asc Research Centre. Based on research data.
The size of the two groups is large enough to test the diﬀerence between the means using the Student’s t-test for
two independent samples. We found a statistically signiﬁcant diﬀerence in the means at 99% level (Table 3).
In order to further investigate the reasons for the low satisfaction of the private operators, we analysed it, taking
into account the typology of contacted public interlocutors. The respondent Pharmaceutical companies which contact
regional Departments and / or General Managers, are less satisﬁed. The proportion of subjects “at least satisﬁed” (a
term aiming to cover all subjects satisﬁed and very satisﬁed) represent only 34.8% of respondents.
Private operators contacting regional Departments and / or General Managers were the less satisﬁed respondents.
The proportion of subjects “at least satisﬁed” (a term that aims at covering all subjects reported to be “satisﬁed” or
“very satisﬁed”) only reach 34.8%. This percentage was slightly exceeded in the group of private operators contacting
the ASL General Manager: among them, the “at least satisﬁed” respondents reach a share of 39.1%. In addition, in
both cases, no operator said to be very satisﬁed. The best result was obtained in the case of subjects cooperating with
the operating units of training, where the percentage of subjects “at least satisﬁed” is around 66.6%, of which 8.3%
are very satisﬁed. Respondents interacting with the Health Director, with pharmaceutical services managers, hospital
activities managers, local activities managers or with the Treasurer declared to be “at least satisﬁed” in a percentage
between 48% and 58%.
We deduced that the satisfaction derived from transactions with operational decision makers (operating units of
training, Treasurer, managers of local activities) was more satisfying compared to the one with executive managers
(Departments and General Management, etc.).
To further analyse the factors inﬂuencing satisfaction, we took into account the association between this variable
and some important analysis factors. The association was measured using Cramer’s V index, a symmetric indicator
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derived from chi-squared statistic and widely used to provide indications on unstructured association between nominal
/ ordinal variables.
Cramer’s V was computed by taking the square root of the chi-squared statistic divided by the sample size and the
length of the minimum dimension of the joint frequency table (the smaller of the number of rows or columns). For
construction, the Cramer’s V, takes values between 0 and 1, extremes included. V is equal to 0 if and only if there is
independence between the characters, it is equal to 1 if and only if there is perfect connection, or at least one of the
two characters perfectly depends on the other.
Table 4. Association calculated using the Cramer’s V, for the variable “Satisfaction” with the variables “Size” and “Frequency of use of outsourc-
ing”.
Cramer’s V for Satisfaction
Size ASL 0.326
Pharma 0.319
Frequency of use of outsourcing ASL 0.262
Pharma 0.272
* Source: B-asc Research Centre. Based on research data.
Table 4 summarizes the main results of the analysis. For all variables taken into account, the index shows a level
of association that is not very pronounced, generally between 0.20 and 0.35, compared to the theoretical maximum of
perfect connection equal to 1.
The higher level of association concerns satisfaction in relation to the size (Table 4), but the value of Cramer’s V
for the association between satisfaction and size in the ASL context is not very large: it is equal to 0.326; calculated
for the pharmaceutical companies, the same index reaches the value of 0.319. In the analysis of the annual frequency,
the index values are lower (0.262 and 0.272 for the ASL and for pharma companies).
These ﬁndings indicate that the size of the company/ASL inﬂuence satisfaction but this eﬀect isn’t so high.
5. Conclusion
Outsourcing is becoming increasingly popular in the context of eﬃciency optimization for the Public Healthcare
sector. The primary aim of this work is providing an overview of the outsourcing satisfaction of speciﬁc operators
of the Italian National Health Service and the outsourcing trend in order to identify prospects for future cooperation
between the public and private operators.
Results suggest that the ASLs still do not invest large amounts of money in outsourcing and even pharmaceutical
companies mainly indicate activities which do not exceed e300,000 (70%). Moreover, the expected outsourcing
investments for the two categories vary in an opposite way. The pharmaceutical companies expect an increase in the
level of average investment in outsourcing, while the ASLs predictions indicate a drastic resizing.
These ﬂuctuations certainly depend on the need of cost reduction and of “linear cuts” in public spending; but the
strategic alliance between outsourcer and outsoursee, that allows to create a relationship of mutual and long-term trust,
consents to determine the organizational structure transformation of the NHS and achieves greater eﬃciency.
Public administration should not break the outsourcing relationship ﬂows with private companies for short-term
cost savings, at the expense of long-term eﬃciency. The pharmaceutical companies have already gone down this path
by introducing the ﬁgure of the market access (MA) manager or Public Aﬀairs Managers (PAM) inside their organi-
zation, in order to make the relationship with the Public Healthcare sector more structured. It could be strategic for
the public health policy makers to create an equivalent professional to make the cost saving plan of public healthcare
services really eﬀective and eﬃcient. Moreover, it would be useful for pharmaceutical companies and local health
authority to further develop the skills of the MA manager.
References
Cappellaro, G., Fattore, G., Torbica, A., 2009. Funding health technologies in decentralized systems: A comparison between italy and spain.
Health policy 92, 313–321.
264   Paolo Mariani et al. /  Procedia Economics and Finance  17 ( 2014 )  256 – 264 
Fattore, G., 1999. Health care and cost containment in the European Union. Ashgate. chapter Cost containment and reforms in the Italian National
Health Service. pp. p.513–46.
Fattore, G., 2012. The impact of the three crises on health in italy: evidence and lack of adequate information systems, in: 46th Scientiﬁc Meeting
of the Italian Statistical Society.
Fornell, C., VanAmburg, D., Morgeson III, F., Anderson, E., Bryant, B., Johnson, M., 2005. The American customer satisfaction index at ten years.
Ann Arbor: Stephen M. Ross School of Business.
Kumar, P., Khan, A.M., Inder, D., Sharma, N., 2013. Job satisfaction of primary health-care providers (public sector) in urban setting. Journal of
family medicine and primary care 2, 227.
Lehmann, E.L., Romano, J.P., 2006. Testing statistical hypotheses. Springer New York.
Macinati, M.S., 2006. Scelte di outsourcing in sanita`. Tendenze nuove 6, 375–404.
Macinati, M.S., 2008a. Outsourcing in the italian national health service: ﬁndings from a national survey. The International Journal of Health
Planning and Management 23, 21–36.
Macinati, M.S., 2008b. The relationship between quality management systems and organizational performance in the italian national health service.
Health Policy 85, 228–241.
Mariani, P., Falotico, R., Data, G., 2011. Aziende sanitarie locali italiane: una lettura dai bandi di gara pubblicati sul web. Tendenze nuove 11,
145–160.
Ministry of Health, http://www.salute.gov.it/, Retrieved: 16/12/2013 .
Parasuraman, A., Zeithaml, V.A., Berry, L.L., 1994. Reassessment of expectations as a comparison standard in measuring service quality: impli-
cations for further research. the Journal of Marketing 58(1), 111–124.
Roberts, V., 2001. Managing strategic outsourcing in the healthcare industry. Journal of healthcare management/American College of Healthcare
Executives 46, 239.
